Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis

Nephrology

Volumn 13, Issue 4, 2008, Pages 331-336

  Mak, Siu Ka ^a   Lo, Kin Yee ^a   Lo, Man Wai ^a   Chan, Shuk Fan ^a   Tong, Gensy Mw ^a   Wong, Ping Nam ^a   Wong, Andrew K M ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

Enteric coated; Lupus nephritis; Mycophenolate sodium

Indexed keywords

ALBUMIN; AZATHIOPRINE; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CREATINE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; ENTERIC COATED TABLET; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HERPES ZOSTER; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MYCOPHENOLIC ACID; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TABLETS, ENTERIC-COATED; TIME FACTORS; TREATMENT OUTCOME;

EID: 43449124089     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00862.x     Document Type: Article

References (25)